MONTREAL, March 19, 2026 /PRNewswire/ -- Congruence Therapeutics today announced that the first participant has been dosed in its Phase 1/1b clinical trial evaluating CGX-926, an oral small-molecule ...
Brand New Day’ just dropped, and this time, things look pretty different (and grim) for Peter Parker. The Marvel Cinematic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results